Changes in drug susceptibility and toxin genes in Staphylococcus aureus isolated from blood cultures at a university hospital

Journal of Infection and Chemotherapy

Volumn 10, Issue 1, 2004, Pages 8-10

  Endo, Hirohisa ^a   Higurashi, Yoshimi ^a   Okuzumi, Katsuko ^a   Hitomi, Shigemi ^b   Kimura, Satoshi ^a,c  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Drug susceptibility; MecA; Staphylococcus aureus; Toxin genes

Indexed keywords

FLOMOXEF; HABEKACIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; PSEUDOMONIC ACID; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS TOXIN; TEICOPLANIN; TOXIC SHOCK SYNDROME TOXIN 1; VANCOMYCIN;

ARTICLE; BACTERIAL GENE; BLOOD CULTURE; DRUG SENSITIVITY; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; STAPHYLOCOCCUS AUREUS; TOXIN SYNTHESIS; UNIVERSITY HOSPITAL;

EID: 1542288090     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0276-0     Document Type: Article

References (12)

1. Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology, 7th Ed. Washington, DC: American Society for Microbiology; 1999. p. 264-82.
2. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520-32.
3. Tanaka T, Okuzumi K, Iwamoto A, Hiramatsu K. A retrospective study of methicillin-resistant Staphylococcus aureus clinical strains in Tokyo University Hospital. J Infect Chemother 1995;1:40-9.
4. Hiramatsu K, Kihara H, Yokota T. Analysis of borderline-resistant strains of methicillin-resistant Staphylococcus aureus using polymerase chain reaction. Microbiol Immunol 1992;36:445-53.
5. Goto S, Okada J, Oguri T, Kanno S, Yamaguchi K, Watanabe T. Report of the Committee for Japanese Standards for Antimicrobial Susceptibility Testing for Bacteria (in Japanese). Chemotherapy 1990;38:102-5.
6. The National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement M100-S12. The National Committee for Clinical Laboratory Standards: Wayne; 2002.
7. Fuchs PC, Jones RN, Barry AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 1990;28:608-9.
8. Saito A. Clinical breakpoints for antimicrobial agents in pulmonary infections and sepsis: report of the Committee for Japanese Standards for Antimicrobial Susceptibility Testing for Bacteria. J Infect Chemother 1995;1:83-8.
9. Grimm H. Interpretive criteria of antimicrobial disk susceptibility tests with flomoxef. Infection 1991;19(Suppl 5):S258-63.
10. Nonoguchi R. Methicillin-resistant Staphylococci isolated from blood culture: epidemiologic characteristics and induction of penicillin-binding protein-2′ by β-lactams (in Japanese). Chemotherapy 1990;38:90-101.
11. Nakazaki N, Uchida K, Hirata Y, Inoue M. Biological properties of blood-derived Staphylococcus aureus strains and their sensitivity to antimicrobial agents (in Japanese). Jpn J Chemother 1998;46:484-90.
12. Okada T, Furukawa S, Miwa K, Sakai R, Sugiyama J. A new exanthematous disease in newborn infants caused by exotoxins producing Staphylococcus aureus; exotoxin production of the isolates and serum levels of antitoxin antibody in the patients and umbilical cord blood (in Japanese). J Jpn Assoc Infect Dis 1999;73:893-900.